Certara Launches v12.0 of SEND Explorer Announcement Certara Launches v12.0 of SEND Explorer December 18, 2024 Radnor, PA – December 18, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed…CertaraDecember 18, 2024
CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard Of Blog CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard Of December 13, 2024 The Centers for Medicare & Medicaid Services (CMS) is piloting a program…CertaraDecember 13, 2024
A Scalable Cloud Platform Accelerates QSP Virtual Patient Generation Poster A Scalable Cloud Platform Accelerates QSP Virtual Patient Generation CertaraDecember 13, 2024
Difference in efficacy between anti-PD-1 and anti-PD-L1 antibodies may be attributable to PD-1:PD-L2 complex inhibition, rather than differences in PD-1:PD-L1 inhibition Poster Difference in efficacy between anti-PD-1 and anti-PD-L1 antibodies may be attributable to PD-1:PD-L2 complex inhibition, rather than differences in PD-1:PD-L1 inhibition CertaraDecember 13, 2024
Cumulative drug binding to Cerebral Amyloid Angiopathy (CAA) predicts ARIA-E incidence for anti-Aβ antibodies in Alzheimer’s Disease Poster Cumulative drug binding to Cerebral Amyloid Angiopathy (CAA) predicts ARIA-E incidence for anti-Aβ antibodies in Alzheimer’s Disease CertaraDecember 13, 2024
QSP model of neuroinflammation: Effect of TREM2 stimulation on microglial activation and function in the context of Alzheimer’s disease Poster QSP model of neuroinflammation: Effect of TREM2 stimulation on microglial activation and function in the context of Alzheimer’s disease CertaraDecember 13, 2024
Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias Poster Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias CertaraDecember 12, 2024
Quantitative Systems Pharmacology (QSP) Summit 2025 Live Events Quantitative Systems Pharmacology (QSP) Summit 2025 The Quantitative Systems Pharmacology (QSP) Summit is a free conference dedicated to fostering an active…CertaraDecember 12, 2024
Delivering High-Quality, Timely Responses to EMA Safety Queries Case Study Delivering High-Quality, Timely Responses to EMA Safety Queries A pharmaceutical company approached us for support with eight safety-related queries from the European Medicines…CertaraDecember 12, 2024
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards Publication Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards Predicting metabolic drug–drug interactions (DDIs) via cytochrome P450 enzymes (CYP) is essential in drug development,…CertaraDecember 12, 2024